Breaking Finance News

MAXIMUS, Inc. (NYSE:MMS) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.

Boasting a price of $57.23, MAXIMUS, Inc. (NYSE:MMS) traded 0.76% higher on the day. With the last stock price close up 1.86% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.05% over the date range. MAXIMUS, Inc. has recorded a 50-day average of $55.46 and a two hundred day average of $56.19. Volume of trade was down over the average, with 279,399 shares of MMS changing hands under the typical 469,994

Zacks Investment Research has upgraded MAXIMUS, Inc. (NYSE:MMS) to Hold in a statement released on 1/12/2017.

Performance Chart


With a total market value of $0, MAXIMUS, Inc. has price-earnings ratio of 21.28 with a one year low of $43.69 and a one year high of $61.68 .

A total of 8 equity analysts have released a ratings update on the company. 6 brokers rating the stock a strong buy, 3 brokers rating the stock a buy, 1 firm rating the stock a hold, 0 firms rating the stock a underperform, and finally 0 firms rating the stock a sell with a consensus target price of $65.00.


MAXIMUS, Inc. provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs. The Health Services segment provides a range of BPS, as well as related consulting services, for state, provincial and national government programs. The Human Services segment provides national, state and local human services agencies with a range of BPS and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.